Literature DB >> 14727752

Treatment planning for prostate brachytherapy using region of interest adjoint functions and a greedy heuristic.

Sua Yoo1, Michael E Kowalok, Bruce R Thomadsen, Douglass L Henderson.   

Abstract

We have developed an efficient treatment-planning algorithm for prostate implants that is based on region of interest (ROI) adjoint functions and a greedy heuristic. For this work, we define the adjoint function for an ROI as the sensitivity of the average dose in the ROI to a unit-strength brachytherapy source at any seed position. The greedy heuristic uses a ratio of target and critical structure adjoint functions to rank seed positions according to their ability to irradiate the target ROI while sparing critical structure ROIs. This ratio is computed once for each seed position prior to the optimization process. Optimization is performed by a greedy heuristic that selects seed positions according to their ratio values. With this method, clinically acceptable treatment plans are obtained in less than 2 s. For comparison, a branch-and-bound method to solve a mixed integer-programming model took more than 50 min to arrive at a feasible solution. Both methods achieved good treatment plans, but the speedup provided by the greedy heuristic was a factor of approximately 1500. This attribute makes this algorithm suitable for intra-operative real-time treatment planning.

Mesh:

Year:  2003        PMID: 14727752     DOI: 10.1088/0031-9155/48/24/006

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  2 in total

1.  Fast patient-specific Monte Carlo brachytherapy dose calculations via the correlated sampling variance reduction technique.

Authors:  Andrew Sampson; Yi Le; Jeffrey F Williamson
Journal:  Med Phys       Date:  2012-02       Impact factor: 4.071

2.  A novel greedy heuristic-based approach to intraoperative planning for permanent prostate brachytherapy.

Authors:  Bin Liang; Fugen Zhou; Bo Liu; Junjie Wang; Yong Xu
Journal:  J Appl Clin Med Phys       Date:  2015-01-08       Impact factor: 2.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.